• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    RenovoRx, Inc. - Common Stock (NQ:RNXT)

    0.8501 -0.0227 (-2.60%)
    Streaming Delayed Price Updated: 10:12 AM EDT, May 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 41,863
    Open 0.8802
    Bid (Size) 0.8508 (500)
    Ask (Size) 0.8678 (100)
    Prev. Close 0.8728
    Today's Range 0.8501 - 0.8802
    52wk Range 0.7006 - 1.450
    Shares Outstanding 36,649,916
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Top movers in Monday's pre-market session ↗
    Via Chartmill
    News headline image
    The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
    From Equity Insider
    Via GlobeNewswire

    Performance

    YTD
    +1.8%
    +1.8%
    1 Month
    -16.7%
    -16.7%
    3 Month
    -14.1%
    -14.1%
    6 Month
    -20.6%
    -20.6%
    1 Year
    -19.8%
    -19.8%

    More News

    Read More
    News headline image
    Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
    Via ACCESS Newswire
    News headline image
    Earnings Scheduled For November 13, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 14, 2025 ↗
    Via Benzinga
    News headline image
    iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    RENOVORX INC (NASDAQ:RNXT) Reports Significant Q3 2025 Revenue Miss and 5% Stock Drop ↗
    Via Chartmill
    News headline image
    RenovoRx (RNXT) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings Economy
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025
    Via ACCESS Newswire
    News headline image
    iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025
    Via ACCESS Newswire
    News headline image
    Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge ↗
    Via Benzinga
    News headline image
    Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗
    Via Chartmill
    News headline image
    RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 27th Annual Global Investment Conference in New York City, September 8-10, 2025
    From RenovoRx, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    Gapping stocks in Friday's session ↗
    Via Chartmill
    News headline image
    What's going on in today's pre-market session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    RenovoRx Revenue Jumps 28 Percent in Q2 ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    RenovoRx Inc. (NASDAQ:RNXT) Q2 2025 Earnings: Revenue Surpasses Estimates, Shares Climb on Positive Results ↗
    Via Chartmill
    News headline image
    RenovoRx Reports Commercial Revenue Growth in the Second Quarter 2025 and Announces Positive Independent Data Monitoring Committee Recommendation to Continue Pivotal Phase III TIGeR-PaC Trial Based on Interim Data Review
    From RenovoRx, Inc.
    Via Business Wire
    News headline image
    RenovoRx Launches Multi-Center Post-Marketing Registry Study to Evaluate Cancer Treatment Delivered by RenovoCath® Device to Solid Tumors
    From RenovoRx, Inc.
    Via Business Wire
    News headline image
    RenovoRx to Host Second Quarter 2025 Financial Results and Business Highlights Conference Call on August 14th at 4:30 p.m. ET
    From RenovoRx, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is RenovoRx, Inc. - Common Stock publicly traded?
    Yes, RenovoRx, Inc. - Common Stock is publicly traded.
    What exchange does RenovoRx, Inc. - Common Stock trade on?
    RenovoRx, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for RenovoRx, Inc. - Common Stock?
    The ticker symbol for RenovoRx, Inc. - Common Stock is RNXT on the Nasdaq Stock Market
    What is the current price of RenovoRx, Inc. - Common Stock?
    The current price of RenovoRx, Inc. - Common Stock is 0.8501
    When was RenovoRx, Inc. - Common Stock last traded?
    The last trade of RenovoRx, Inc. - Common Stock was at 05/13/26 10:12 AM ET
    What is the market capitalization of RenovoRx, Inc. - Common Stock?
    The market capitalization of RenovoRx, Inc. - Common Stock is 31.16M
    How many shares of RenovoRx, Inc. - Common Stock are outstanding?
    RenovoRx, Inc. - Common Stock has 31M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.